Ding Tao, Hardiman Paul J, Petersen Irene, Wang Fang-Fang, Qu Fan, Baio Gianluca
Department of Statistical Science, University College London, London, United Kingdom.
Institute for Women's Health, University College London Medical School, London, United Kingdom.
Oncotarget. 2017 Jul 12;8(56):96351-96358. doi: 10.18632/oncotarget.19180. eCollection 2017 Nov 10.
The prevalence of PCOS was investigated in many studies in different continents. However, there is no established prevalence of PCOS for distinct ethnic groups. In the current analysis, we conducted searches in PubMed, The Cochrane Library, EMBASE, CINAHL up to Jan. 2017 to identify studies reporting prevalence of PCOS in the general female population. Forty-two studies were identified, with 13 eligible for evidence synthesis. The prevalence among different ethnicity was estimated using random effect modelling. Our results suggested the lowest prevalence in Chinese women(2003 Rotterdam criterion: 5.6% 95% interval: 4.4-7.3%), and then in an ascending order for Caucasians (1990 NIH criterion: 5.5% 95% interval: 4.8-6.3%), Middle Eastern (1990 NIH 6.1% 95% interval: 5.3-7.1%; 2003 Rotterdam 16.0% 95% interval: 13.8-18.6%; 2006 AES 12.6% 95% interval: 11.3-14.2%), and Black women (1990 NIH: 6.1% 95% interval: 5.3-7.1%).There is variation in prevalence of PCOS under different diagnostic criteria and across ethnic groups. This emphasises the need for ethnicity-specific guidelines for PCOS to prevent under- or over-diagnosis of the condition given that under-diagnosis may lead to rapid conversion of metabolic disorders for patients whereas over-diagnosis may exert negative psychological effects on patients which worsens the major symptoms of PCOS.
在不同大陆的许多研究中都对多囊卵巢综合征(PCOS)的患病率进行了调查。然而,目前尚无针对不同种族群体的确切PCOS患病率。在本次分析中,我们检索了截至2017年1月的PubMed、Cochrane图书馆、EMBASE、CINAHL,以确定报告一般女性人群中PCOS患病率的研究。共识别出42项研究,其中13项符合证据综合分析的条件。使用随机效应模型估计了不同种族的患病率。我们的结果表明,中国女性的患病率最低(2003年鹿特丹标准:5.6%,95%置信区间:4.4 - 7.3%),其次是白种人(1990年美国国立卫生研究院标准:5.5%,95%置信区间:4.8 - 6.3%)、中东地区人群(1990年美国国立卫生研究院标准:6.1%,95%置信区间:5.3 - 7.1%;2003年鹿特丹标准:16.0%,95%置信区间:13.8 - 18.6%;2006年美国内分泌学会标准:12.6%,95%置信区间:11.3 - 14.2%)以及黑人女性(1990年美国国立卫生研究院标准:6.1%,95%置信区间:5.3 - 7.1%)。不同诊断标准下以及不同种族群体之间PCOS的患病率存在差异。这强调了制定针对特定种族的PCOS指南的必要性,以防止对该疾病的诊断不足或过度诊断,因为诊断不足可能导致患者代谢紊乱迅速转变,而过度诊断可能对患者产生负面心理影响,进而加重PCOS的主要症状。